CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders, e.g., disease-specific proteins, ...read more
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders, e.g., disease-specific proteins, receptors, enzymes, and genes.
CNS & Neurological Disorders - Drug Targets publishes guest-edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts original research articles, letters, reviews, and drug clinical trial studies for publication.
As the discovery, identification, characterization, and validation of novel human drug targets for neurological and CNS drug discovery continue to grow, this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
